Based on the forecasted data for respiratory system medicine sales in Belgium, the value as a percentage of total sales is expected to decline slightly from 8% in 2024 to 7.9% from 2025 through 2028. The year-on-year variation shows a consistent decrease of 1.25% starting from 2024. From 2023 levels, this marks a stabilization trend with minimal annual fluctuation, suggesting a plateau in market share over the next five years. The last CAGR illustrates a negligible average annual change, reinforcing the stability in this segment.
- Finalize year: 7.9%
- Year-on-year variation: -1.25%
- Stable market outlook
Future trends to watch for include advancements in respiratory medicine technology, regulatory changes, competitive landscape shifts, and potential impacts from ongoing healthcare reforms. Monitoring these factors will be critical to understanding future market dynamics.
